Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.3K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

920
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
920
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

893
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
893
Hepatitis01:25

Hepatitis

42
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

493
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
493
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

1.1K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.1K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Direct Oral Anticoagulant Type and Dose in Atrial Fibrillation With Decompensated Cirrhosis: A Propensity-Matched Analysis.

Gastro hep advances·2026
Same author

Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)?

European radiology·2026
Same author

The Nutrition Landscape in Chronic Liver Disease.

Digestive diseases and sciences·2026
Same author

Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis.

Journal of hepatology·2026
Same author

Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease.

Gut microbes·2026
Same author

Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis.

Liver international : official journal of the International Association for the Study of the Liver·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Apr 4, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

936

Cirrosis biliar primaria

Elizabeth J Carey1, Ahmad H Ali1, Keith D Lindor2

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USA.

Lancet (London, England)
|September 15, 2015
PubMed
Resumen
Este resumen es generado por máquina.

La cirrosis biliar primaria (CBP) es una enfermedad hepática crónica. Si bien el ácido ursodeoxicólico (UDCA) mejora la supervivencia, se necesitan nuevas terapias para los que no responden, y las hormonas receptoras nucleares son prometedoras.

Más Videos Relacionados

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

18.0K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.8K

Videos de Experimentos Relacionados

Last Updated: Apr 4, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

936
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

18.0K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.8K

Área de la Ciencia:

  • Hepatología
  • Inmunología
  • Gastroenterología

Sus antecedentes:

  • La cirrosis biliar primaria (CBP) es una enfermedad hepática colestática crónica caracterizada por la destrucción autoinmune de los conductos biliares intrahepáticos pequeños.
  • Los anticuerpos antimitocondriales (AMAs, por sus siglas en inglés) son un marcador serológico específico, presente en aproximadamente el 95% de los pacientes con cáncer de próstata.
  • La fatiga y el prurito son síntomas comunes, independientemente de la gravedad de la enfermedad.

Objetivo del estudio:

  • Revisar la comprensión actual de la epidemiología, la patogénesis y la historia natural de la CBP.
  • Discutir las estrategias actuales de manejo y las complicaciones de la CBP.
  • Introducir nuevas opciones terapéuticas, incluida la investigación sobre las hormonas de los receptores nucleares.

Principales métodos:

  • Revisión de la literatura existente sobre la cirrosis biliar primaria.
  • Análisis de los datos de ensayos clínicos para la eficacia del ácido ursodeoxicólico (UDCA).
  • Exploración de los resultados de las investigaciones sobre nuevos objetivos terapéuticos.

Principales resultados:

  • El ácido ursodeoxicólico (UDCA) ha mejorado la supervivencia sin trasplante en pacientes con cáncer de próstata.
  • Aproximadamente el 40% de los pacientes con CBC presentan una respuesta bioquímica inadecuada a la UDCA.
  • El trasplante de hígado ofrece excelentes resultados para pacientes con cirrosis descompensada.

Conclusiones:

  • A pesar de los beneficios del UDCA, una proporción significativa de pacientes con cáncer de próstata requieren tratamientos alternativos.
  • La investigación sobre las hormonas receptoras nucleares presenta vías prometedoras para nuevas terapias de PBC.
  • Una comprensión completa de los aspectos multifacéticos de la CBP es crucial para avanzar en la atención al paciente.